ArticleCancers2025

Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving Trastuzumab Deruxtecan.

Alessio Molfino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.